JCO Article Insights: ESPAC4 Long-Term Follow-Up in Pancreatic Cancer

<p>In this JCO Article Insights episode, host Joseph Mathew summaries Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial, by Palmer, et al published December 5, 2024.</p> <h2>Transcript</h2> <p class="MsoNormal" style="margin: 12.0pt 0in 12.0pt 0in;"> <span style= "font-family: arial, helvetica, sans-serif;"><strong style= "mso-bidi-font-weight: normal;"><span lang="EN" xml:lang= "EN">Joseph Mathew:</span></strong></span></p> <p class="MsoNormal" style="margin: 12.0pt 0in 12.0pt 0in;"> <span style= "font-family: arial, helvetica, sans-serif;"><span lang="EN" xml:lang="EN">Hello and welcome to the</span> <span lang="EN" xml:lang="EN"><a href="https://ascopubs.org/journal/jco/podcast" target="_blank" rel="noopener"><em style= "mso-bidi-font-style: normal;">Journal of Clinical Oncology Article Insights</em></a></span><span lang="EN" xml:lang="EN">. I'm your host, Joseph Mathew, and today we will be discussing the article "</span><span lang="EN"...